Dog /

Breed profile · FDA CVM July 2026 extract

Pekingese adverse-event record

Adverse-event filings for Pekingese (Dog) in the FDA Center for Veterinary Medicine openFDA extract. Browse dog breeds, reactions, and outcomes below.

#70 of 510
by report volume (all breeds)
2,552
FDA CVM reports on file
4.0%
death-coded share of reports
#178 of 275
by death-coded share (≥50 reports)

How the 2,552 reports break down

By recorded gender -- every report on file for Pekingese, no filtering.

Annual report volume

Annual adverse-event report trend Yearly FDA CVM adverse-event report counts for this breed. 117 87.75 58.5 29.25 0 2019 2020 2021 2022 2023 2024 2025 2026 Reports filed Death-coded reports
Annual report volume for Pekingese drawn from FDA CVM filings.

Data updated September 2026

The verdict

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Pekingese ranks #70 of 510 by total reports (2,552) and #178 of 275 by death-coded share (4.0%). National dual: Retriever - Labrador is #1 of 510 by total adverse-event reports (93,675) at death-coded-share rank 195 of 275 breeds with at least 50 reports (3.7%); separately, Atlantic Salmon (Salmo salar) is #1 highest death-coded share at 99.0% (report rank #233).

93,675
Retriever - Labrador reports (#1)
99.0%
Atlantic Salmon (Salmo salar) death share (#1)
#70
This breed, reports of 510
#178
This breed, death share of 275

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Pekingese has 2,552 reports now versus 2,541 in that prior snapshot: 11 more (0.4%).

Report change
+11
Death-coded reports
+2
Death-coded share
+0.1 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Pekingese changes

Total Reports

2,552

High report volume

Deaths Reported

102

of 2,552 reports

Death-coded share of reports

4.0%

Below-median death-coded share

Avg Age at Report

7.0 yr

6.6 kg avg weight

Breed Safety Scorecard

A- (81/100)

A weighted composite across 4 of 4 dimensions, each benchmarked against every tracked breed with at least 200 reports (n=185). Dimensions with insufficient data drop out and their weight redistributes to the rest, so a missing input never silently deflates the score.

Death rate C+
4.0%

Share of reports coded as a fatality

Euthanasia rate B+
1.6%

Share of reports resulting in euthanasia

Full recovery rate A+
41.4%

Share of reports coded "Recovered/Normal"

5-year trend A
-34%

Change in annual report volume over the last 5 complete years

Death-Coded Outcome Share

Pekingese death-coded reports 4.0%
Cross-breed median

4.0% of 2,552 pekingese reports involved a death outcome.

How to read this number

Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.

Where Pekingese's death-coded share sits among indexed breeds

Death-coded share of FDA CVM reports, breeds with ≥50 reports (July 2026 extract)

4% 35th percentile Higher share than 35% of 275 indexed breeds

5%–10%: 1 indexed breeds (0%). This entry sits in this band. 20%–25%: 2 indexed breeds (1%). Above this entry. 25%–30%: 3 indexed breeds (1%). Above this entry. 30%–35%: 4 indexed breeds (1%). Above this entry. 35%–40%: 5 indexed breeds (2%). Above this entry. 40%–45%: 6 indexed breeds (2%). Above this entry. 45%–50%: 3 indexed breeds (1%). Above this entry. 50%–55%: 7 indexed breeds (3%). Above this entry. 55%–60%: 7 indexed breeds (3%). Above this entry. 60%–65%: 21 indexed breeds (8%). Above this entry. 65%–70%: 11 indexed breeds (4%). Above this entry. 70%–75%: 15 indexed breeds (5%). Above this entry. 75%–80%: 13 indexed breeds (5%). Above this entry. 80%–85%: 11 indexed breeds (4%). Above this entry. 85%–90%: 12 indexed breeds (4%). Above this entry. 90%–95%: 12 indexed breeds (4%). Above this entry. 95%–100%: 142 indexed breeds (52%). Above this entry. Pekingese 5% 100% every breed with ≥50 FDA reports, bucketed by value

Each bar is a band; taller bars hold more indexed breeds. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source FDA Center for Veterinary Medicine, openFDA adverse event extract (PlainBreed) · July 2026 extract

This histogram uses the same ≥50-report cohort as the highest death-coded share ranking. A higher share means more of this breed's reported events were death-coded, not a mortality rate for living animals.

Average weight at time of report: 6.6 kg (14.6 lbs)

Top Reported Reactions

Vomiting 596
Emesis 402
Lethargy (see also Central nervous system depression in 'Neurological') 297
Lack of efficacy (ectoparasite) - flea 230
Diarrhoea 175
Seizure NOS 159
Anorexia 116
Lack of efficacy - NOS 111
Pruritus 92
Lack of efficacy (endoparasite) - hookworm 82
Behavioural disorder NOS 79
Not eating 65
Ataxia 64
Other abnormal test result NOS 61
Decreased appetite 61

Most Referenced Drugs

Milbemycin Oxime + Spinosad 636
Spinosad 396
Afoxolaner 145
Ivermectin + Pyrantel As Pamoate Salt 134
Fluralaner Chew Tablets 101
Moxidectin 90
Oclacitinib Maleate 80
Carprofen 67
Fluralaner 13.64% 12-Week Chew 64
Pyrantel Pamoate;Sarolaner 63
Milbemycin Oxime + Praziquantel 57
Nitenpyram 56
Sarolaner 56
Selamectin 50
Imidacloprid + Moxidectin 49

Outcome Breakdown

Recovered/Normal
1,057 (45.3%)
Outcome Unknown
657 (28.2%)
Ongoing
415 (17.8%)
Recovered with Sequela
101 (4.3%)
Died
62 (2.7%)
Euthanized
40 (1.7%)

Gender Distribution

Male 1,319 (51.7%)
Female 1,157 (45.3%)
Unknown 69 (2.7%)
Mixed 7 (0.3%)

Reports by Year

Year Reports Trend
2010 119
2011 187
2012 299
2013 281
2014 236
2015 230
2016 197
2017 184
2018 155
2019 109
2020 117
2021 105
2022 84
2023 71
2024 101
2025 69
2026 8

Pekingese: high-volume FDA adverse-event cohort

Signature read: 2,552 reports place Pekingese in the upper third of breed filing volume (#70 of 510). According to FDA CVM filings indexed on PlainBreed as of July 2026 extract, Pekingese sits at #70 of 510 by report volume among all breeds and #60 of 298 among dog breeds, with 2,552 reports and 102 (4.0%) death-coded. On death-coded share among breeds with ≥50 reports, it ranks #178 of 275. Mean age at report: 7.0 years, average weight 6.6 kg (14.6 lbs).

Top reported signs: Vomiting (596), Emesis (402), Lethargy (see also Central nervous system depression in 'Neurological') (297). Most-referenced drug: Milbemycin Oxime + Spinosad (636 reports), followed by Spinosad (396) and Afoxolaner (145).

Outcome coding on 2,332 status-recorded reports is dominated by Recovered/Normal (45.3%). Annual submissions ranged 8-2,026 across 17 years on file.

Dog Breeds With a Similar Report Volume

Showing 6 of 297 dog breeds in our dataset, ranked by closest report volume.

Nationwide breeds with similar profiles

High-volume peer sets for Pekingese drawn from openFDA outside the Dog family so the neighborhoods are not species containment (the similar-volume list above stays within species).

Similar death-coded share

Nearest other-species breeds with ≥50 reports (4.0% death-coded here).

Similar average weight

Nearest other-species breeds by reported average weight (6.6 kg here).

What to do with this dog

A report does not prove a drug caused the reaction, and popular breeds simply generate more reports.

Frequently Asked Questions

How many FDA adverse event reports involve Pekingese?
There are 2,552 adverse event reports involving Pekingese in the FDA database, of which 102 were death-coded (4.0% of those reports). That is a share of REPORTED events, not a mortality rate for the breed: adverse events reach the FDA when something goes wrong, so the denominator is reports, never the population of animals. According to the same FDA CVM extract, Pekingese ranks #70 of 510 by report volume among all breeds PlainBreed indexes (#60 of 298 among dog breeds).
Where does Pekingese sit among other breeds in PlainBreed's corpus?
According to FDA CVM report volume, Pekingese is #70 of 510 breeds indexed on PlainBreed (same ordering as the most-reported-breeds ranking). Inside Dog, it is #60 of 298. Among breeds with at least 50 reports, its death-coded share ranks #178 of 275 (same cohort as highest-death-rate). These are placement ranks in the reporting corpus, not clinical risk scores.
What are the most common adverse reactions reported for Pekingese?
The most commonly reported adverse reactions for Pekingese are Vomiting (596 reports), Emesis (402 reports), Lethargy (see also Central nervous system depression in 'Neurological') (297 reports), Lack of efficacy (ectoparasite) - flea (230 reports), Diarrhoea (175 reports).
What drugs are most frequently associated with Pekingese adverse events?
The drugs most frequently referenced in Pekingese adverse event reports are Milbemycin Oxime + Spinosad (636 reports), Spinosad (396 reports), Afoxolaner (145 reports), Ivermectin + Pyrantel As Pamoate Salt (134 reports), Fluralaner Chew Tablets (101 reports).
What is the average age of Pekingese in adverse event reports?
The average age of Pekingese at the time of adverse event reports is 7.0 years, with an average weight of 6.6 kg (14.6 lbs).

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Pekingese (Dog), extract as of July 2026 extract. 2,552 reports · 102 death-coded (4.0% of reports, not a mortality rate) · #70 of 510 by volume.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →